A recent case of breast cancer patient from Ontario captured the attention of media. As per reports, Anzarut, a 35-year-old mother of two, was diagnosed with serious breast cancer.

Jill and her father were reportedly shocked when she could not qualify in Ontario's health insurance program, which provides life saving drug, Herceptin.

Shocked with the judgment made by Diane McArthur, who decides what treatments the province funds as executive officer of the Ontario Public Drug Programs, she echoed her plea through various medical channels.

Responding to the allegations made by Jill on the prevalent red tapism in the system, Ontario’s Health Minister claims that such eye catchy antics by patients cannot force the government’s decision. However, Deb Matthews assured that complete justice would be given to all the patients who qualify for the programme.

Further, Ms. Matthews claims that with the cost of therapy pegged at $40,000 for a one-year, it’s really difficult for the government to provide drug to normal cases as per Ontario’s guidelines for breast-cancer treatment.

However, Ellen Warner, an Oncologist at Sunnybrook Health Sciences Centre and Director of the hospital’s PYNK breast cancer program for young women, claims that there is sufficient evidence available in the case of Jill to qualify for the treatment.